EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
Viral Hepatitis Elimination 202224–25 February 2022
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| PO-07 | Clinical and epidemiological characteristics of Chronic Viral Hepatitis in Kazakhstan: data from Unified Nationwide Electronic Healthcare System 2014-2019 | Dmitriy Syssoyev |  Received |
 |
|||
| PO-18 | Are men who have sex with men (MSM) in Europe protected from Hepatitis A and B? Results from the European MSM internet survey (EMIS-2017) | Michael Brandl | Received |
|
|||
| PO-21 | HCV micro-elimination strategies for the PWUD population of the Balearic Islands | Jeffrey Lazarus | Received |
|
|||
| PO-26 | Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands | Cas Isfordink | Received |
|
|||
| PO-27 | The prevalence of Hepatitis B in the UK: a systematic review | Sema Mandal | Received |
|
|||
| PO-28 | Mortality rates among individuals with laboratory diagnosed hepatitis B virus (HBV) infection: England, 1999-2018 | Sema Mandal | Received |
|
|||
| PO-36 | A model for a pharmacist-led point-of-care hepatitis C treatment service in outreach settings | Jacob Smiles | Received |
|
|||
| PO-39 | Immunity to hepatitis A and hepatitis B among men who have sex with men (MSM) attending sexual health clinics in London and the North of England, 2017-18 | Sema Mandal | Received |
|
|||
| PO-52 | The Mobile pathway, an opportunity in providing Hepatitis C services, during the challenging times of COVID-19 | Anne Manjalee Liyanage | Received |
|
|||
| PO-56 | Antenatal hepatitis C testing and care in maternity services in England, a national survey | Amoolya Vusirikala | Received |
|
|||
| PO-57 | Primary care physician adoption of hepatitis C virus treatment in United States Medicaid programs | Shashi Kapadia | Received |
|
|||
| PO-63 | FIB-5 and/or FIB-4 index for hepatic fibrosis assessment in chronic hepatitis B patients | Mohamed Abdel-Samiee | Received |
|
|||
| PO-64 | Trends in hepatitis C treatment and chronic prevalence over the last decade among people who inject drugs | Eva Emanuel | Received |
|
|||
| PO-66 | FOCUS Project: preliminary results toward Hepatitis C Virus screening and elimination in Almería, Spain | Anny Camelo Castillo | Received |
|
|||
| PO-69 | Screening for hepatitis C virus reinfection using a behaviour-based risk score among HIV-positive men who have sex with men | Kris Hage | Received |
|
|||
| PO-73 | Combined COVID-19 vaccination and hepatitis C virus and HIV screening intervention for high-risk populations at a mobile testing unit in Madrid, Spain | Jeffrey V Lazarus | Received |
|
|||
| PO-75 | Demonstrating control of perinatal transmission of hepatitis B in the UK: a low prevalence country with universal antenatal screening and ive neonatal immunisation programmes | Sema Mandal | Received |
|
|||
| PO-76 | Community values and preferences regarding decentralisation and task-shifting of HCV services - results from an international online survey | Cary James | Received |
|
|||
| PO-78 | Demographic characteristics and viral diversity in hepatitis B infected pregnant women in England: implications for control of maternal to child transmission | Eleanor Clarke | Received |
|
|||
| PO-82 | Enhancing Universal Hepatitis B and C Screening via the Electronic Medical Record: A Case Study | Mageras Anna | Received |
|
|||
| PO-84 | Outcome of Hepatitis C Virus co-infection treatment among Human Immunodeficiency Virus-infected people who inject drugs: an Egyptian real-life experience. | ahmed cordie | Received |
|
|||
| PO-88 | Approaches for a Hepatitis C-free city: preliminary results | Angelica Luque | Received |
|
|||
| PO-89 | Direct acting antiviral treatment for chronic hepatitis C are successful in Egyptian patients with chronic hepatitis C virus infection after a geographically focused, community-based HCV screening | Mohamed Abdel-Samiee | Received |
|
|||
| PO-92 | Hepatitis C virus micro-elimination approach in vulnerable population in the South of Spain | Jesús Aranda López | Received |
|
|||
| PO-94 | Screening for hepatitis C virus in high risk categories of Romanian population and updated prevalence data | Speranta Iacob | Received |
|
|||
| PO-97 | Microelimination of Hepatitis C in patients with substance use disorders | Ruben Carvalho | Received |
|
|||
| PO-98 | Screening for hepatitis B virus in high risk categories of Romanian population and updated prevalence data | Speranta Iacob | Received |
|
|||
| PO-99 | No reinfections: elimination is feasible in drug adicctions users | Esther Rodríguez Candelaria | Received |
|
|||
| PO-105 | Safety and efficacy of crushed sofosbuvir/velpatasvir in hepatitis C infected patients - a case series | Shobha Joshi | Received |
|
|||
| PO-107 | Going, going, gone? Routine Emergency Department hepatitis C testing can drive and monitor elimination | Kate Drysdale | Received |
|
|||
| PO-111 | Estimated prevalence of chronic hepatitis B in Denmark | Signe Bollerup | Received |
|
|||
| PO-112 | Framework for hepatitis C virus (HCV) Micro-Elimination in Ho Chi Minh City (HCMC), Vietnam: A Path to National HCV Elimination | Thanh Kim | Received |
|
|||
| PO-113 | Is it possible a real Point-Of-Care? Feasibility evaluation of telemedicine project to overcome the last barriers to treatment in PWIDs. | Daniela Maggi | Received |
|
|||
| PO-114 | Characteristics of childhood hepatitis B diagnosed cases reported to the national enhanced surveillance system, England 2017-2021 | Eleanor Clarke | Received |
|
|||
| PO-115 | HCV elimination among People Who Use Drug in Rome outside the hospital setting is possible during the COVID19 pandemic. | Elisabetta Teti | Received |
|
|||
| PO-117 | What can Europe learn from HCP knowledge and attitudes towards hepatitis A vaccination in the US? | Anar ANDANI | Received |
|
|||
| PO-118 | Point of care screening tests for hepatitis B and commitment of a dedicated nurse lead to successful linkage to care of ethnic minorities | Axelle Vanderlinden | Received |
|
|||
| PO-121 | A model for detection and linkage to care of hepatitis C infected persons in prisons in Croatia | Lucija Virovic Jukic | Received |
|
|||
| PO-122 | The Elimination of hepatitis C by the Cherokee Nation | Jorge Mera | Received |
|
|||
| PO-123 | implementing a simplified model of care for hepatitis c virus micro-elimination among people living with human immunodeficiency virus who inject drugs in Egypt | Rahma Mohamed | Received |
|
|||
| PO-124 | a single centre 2020 view of blood borne viruses and risk behaviour in male irish prisoners | CATHAL CLIFFORD | Received |
|
|||
| PO-128 | Evidence of hepatitis B virus (HBV) horizontal transmission and a significant proportion of adults remaining at high risk of horizontal HBV transmission are barriers to HBV elimination in Ho Chi Minh City (HCMC), Vietnam | Thanh Kim | Received |
|
|||
| PO-136 | Hepatitis C virus in people who inject drugs at the Needle and Syringe Program in Uppsala, Sweden | Elsa Kagstrom | Received |
|
|||
| PO-137 | Phyloepidemiological analysis of antiviral resistance to NS5A inhibitors in subtype 1a in England post-rollout of direct acting antivirals | Daniel Bradshaw | Received |
|
|||
| PO-138 | Combined telephone and home assessment and home treatment delivery improves drug service client access to hepatitis c care and treatment uptake during the COVID-19 pandemic | Natasha Baker | Received |
|
|||
| PO-139 | Hepatitis B virus vaccination among people with human immunodeficiency virus in the Netherlands | Anders Boyd | Received |
|
|||
| PO-140 | Update on hepatitis A in Europe a systematic review on outbreaks and burden of disease in 11 countries, 20012021 | Kassiani Mellou | Received |
|
|||
| PO-141 | Covid-19 pandemic: a significant barrier for hepatitis c elimination for people who use drugs (PWUD) in Greece | Pinelopi Antonakaki | Received |
|
|||
| PO-143 | Estimating rates of hepatitis C virus reinfection among patients receiving antiviral treatment in England | Matthew Hibbert | Received |
|
|||
| PO-144 | Hepatitis C virus test positivity among pregnant women in England between 2016-2017 | Matthew Hibbert | Received |
|
|||
| PO-147 | Seroprevalence of vaccine derived Hepatitis B antibodies in Germany: results from the German Health Survey for Children and Adolescents, 2014-2017 | Ida Sperle | Received |
|
|||
| PO-149 | Implementation of rapid point-of-care diagnostic systems to support HCV micro-elimination strategies in a tertiary hospital in Spain. | Antonio Madejón | Received |
|
|||
| PO-150 | Clinical characteristics and survival of patients with cirrhosis and hepatocellular carcinoma in The Gambia | Erwan Vo Quang | Received |
|
|||
| PO-155 | How should reinfection rates be measured and presented? Pitfalls and practical lessons from the Trap HepC project | Magnus Gottfredsson | Received |
|
|||
| PO-161 | Effectiveness of non-nurse, non-doctor Community Liaison Officer programme in testing and treating hepatitis C in homeless populations | F Javier Vilar | Received |
|
|||
| PO-167 | National Hepatitis Elimination Profiles: Progress Towards HBV and HCV Elimination in the Americas | Vanessa Nunez | Received |
|
|||
| PO-168 | Hepatitis C virus treatment uptake among marginalized people who inject drugs: a registry based study | Kristian Malme | Received |
|
|||
| PO-172 | The Canadian real-world 8 years experience with DAA-based regimens in genotype 3: Preliminary data | Isaac Ruiz | Received |
|
|||
| PO-179 | Hepatitis C screening in a psychiatric emergency department: 8-months results | Ana Barreira | Received |
|
|||
| PO-183 | TESTATE C Plus: an online self-sampling intervention for hepatitis C in gay, bisexual and other men who have sex with men and trans women in Spain | Cristina Agustí | Received |
|
|||
| PO-195 | To reconvene patients who were lost to follow-up is a useful strategy to eliminate Hepatitis C Virus. Results from the multicenter French study RECONVOCC. | Armand Abergel | Received |
|
|||
| PO-199 | Hepatitis A and B Infection and Vaccination among MSM in Ireland: an Analysis of the Findings from the European MSM Internet Survey 2017 (EMIS-2017) | Philippa White | Received |
|
|||
| PO-202 | Lack of Hepatitis B vaccination among high-risk populations: A single-center study in an addiction treatment center | Franois Villeret | Received |
|
|||
| PO-203 | Mind the Gap: Preliminary evaluation of the prevention of mother-to-child transmission of Hepatitis B care cascade in rural western Uganda | Sahal Thahir | Received |
|
|||
| PO-204 | Contact tracing in networks of people who inject drugs with Hepatitis C is the most efficient testing strategy to maintain Hepatitis C elimination post 2030 | RYan Buchanan | Received |
|
|||
| PO-207 | Targeted immunotherapy with heterologous prime-boost and adjuvanted hepatitis B core (HBc)/surface (HBs) proteins in adult chronic hepatitis B patients showed positive HBc- and HBs-specific CD8 and CD4 T cell responses in a phase I/II trial | Kristien Swinnen | Received |
|
|||
Viral Hepatitis Elimination 2022
24–25 February 2022
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 24/02/2022 TO 24/02/2023
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
|
|
